1. A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma. (December 2019) Authors: Hida, Toyoaki; Velcheti, Vamsidhar; Reckamp, Karen L.; Nokihara, Hiroshi; Sachdev, Pallavi; Kubota, Tomoki; Nakada, Takuya; Dutcus, Corina E.; Ren, Min; Tamura, Tomohide Journal: Lung cancer Issue: Volume 138(2019) Page Start: 124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A profile on capmatinib in treating adult patients with metastatic NSCLC tumors with MET exon 14 skipping mutations. Issue 1 (2nd January 2022) Authors: Hida, Toyoaki Journal: Expert review of precision medicine and drug development Issue: Volume 7:Issue 1(2022) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non‐small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX‐Lung 3. Issue 9 (25th July 2015) Authors: Kato, Terufumi; Yoshioka, Hiroshige; Okamoto, Isamu; Yokoyama, Akira; Hida, Toyoaki; Seto, Takashi; Kiura, Katsuyuki; Massey, Dan; Seki, Yoko; Yamamoto, Nobuyuki Journal: Cancer science Issue: Volume 106:Issue 9(2015:Sep.) Page Start: 1202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial. Issue 10089 (1st July 2017) Authors: Hida, Toyoaki; Nokihara, Hiroshi; Kondo, Masashi; Kim, Young Hak; Azuma, Koichi; Seto, Takashi; Takiguchi, Yuichi; Nishio, Makoto; Yoshioka, Hiroshige; Imamura, Fumio; Hotta, Katsuyuki; Watanabe, Satoshi; Goto, Koichi; Satouchi, Miyako; Kozuki, Toshiyuki; Shukuya, Takehito; Nakagawa, Kazuhiko; Mi... Journal: Lancet Issue: Volume 390:Issue 10089(2017) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Anaplastic lymphoma kinase expression in small‐cell lung cancer. Issue 1 (23rd May 2019) Authors: Kondoh, Chiaki; Horio, Yoshitsugu; Hayashi, Yuko; Ebi, Hiromichi; Hida, Toyoaki; Hasegawa, Yoshinori; Yatabe, Yasushi Journal: Histopathology Issue: Volume 75:Issue 1(2019) Page Start: 20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Anaplastic lymphoma kinase gene rearrangements in patients with advanced‐stage non‐small‐cell lung cancer: CT characteristics and response to chemotherapy. (27th December 2013) Authors: Park, Jangchul; Yamaura, Hidekazu; Yatabe, Yasushi; Hosoda, Waki; Kondo, Chiaki; Shimizu, Junichi; Horio, Yoshitsugu; Yoshida, Kimihide; Tanaka, Kosuke; Oguri, Tomoyo; Kobayashi, Yoshihisa; Hida, Toyoaki Journal: Cancer medicine Issue: Volume 3:Number 1(2014:Feb.) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Anaplastic lymphoma kinase gene rearrangements in patients with advanced‐stage non‐small‐cell lung cancer: CT characteristics and response to chemotherapy. (27th December 2013) Authors: Park, Jangchul; Yamaura, Hidekazu; Yatabe, Yasushi; Hosoda, Waki; Kondo, Chiaki; Shimizu, Junichi; Horio, Yoshitsugu; Yoshida, Kimihide; Tanaka, Kosuke; Oguri, Tomoyo; Kobayashi, Yoshihisa; Hida, Toyoaki Journal: Cancer medicine Issue: Volume 3:Number 1(2014:Feb.) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. ASP8273 tolerability and antitumor activity in tyrosine kinase inhibitor‐naïve Japanese patients with EGFR mutation‐positive non‐small‐cell lung cancer. Issue 8 (29th June 2018) Authors: Azuma, Koichi; Nishio, Makoto; Hayashi, Hidetoshi; Kiura, Katsuyuki; Satouchi, Miyako; Sugawara, Shunichi; Hida, Toyoaki; Iwamoto, Yasuo; Inoue, Akira; Takeda, Koji; Ikeda, Satoshi; Nakagawa, Tomoki; Takeda, Kentaro; Asahina, Seitaro; Komatsu, Kanji; Morita, Satoshi; Fukuoka, Masahiro; Nakagawa, ... Journal: Cancer science Issue: Volume 109:Issue 8(2018) Page Start: 2532 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Asthma caused by durvalumab after chemoradiotherapy in two patients with non‐small cell lung cancer. Issue 9 (19th August 2021) Authors: Uemura, Takehiro; Fukumitsu, Kensuke; Maeno, Ken; Fukuda, Satoshi; Onuki, Tomohiro; Kanemitsu, Yoshihiro; Oguri, Tetsuya; Niimi, Akio; Hida, Toyoaki Journal: Respirology case reports Issue: Volume 9:Issue 9(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial. Issue 10066 (21st January 2017) Authors: Rittmeyer, Achim; Barlesi, Fabrice; Waterkamp, Daniel; Park, Keunchil; Ciardiello, Fortunato; von Pawel, Joachim; Gadgeel, Shirish M; Hida, Toyoaki; Kowalski, Dariusz M; Dols, Manuel Cobo; Cortinovis, Diego L; Leach, Joseph; Polikoff, Jonathan; Barrios, Carlos; Kabbinavar, Fairooz; Frontera, Osva... Journal: Lancet Issue: Volume 389:Issue 10066(2017) Page Start: 255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗